Melody Healthcare is an API manufacturer based in India. It holds 12 active US drug master files and 13 valid CEPs across a filed portfolio of 15 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 12 December 2025 as VAI. Customs aggregates show $10.0M of exports covering 420 molecules to 43 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Mumbai, India | Not on file |
| Mumbai, India | Not on file |
| Boisar, India | Not on file |
| Boisar, India | Not on file |
| Palghar, India | 3009118300 |
| Molecule | Regulators | Docs |
|---|---|---|
| Albuterol | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Tigecycline | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Salmeterol | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Rosuvastatin | EDQM, US FDA | 3 |
| Terbutaline | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Formoterol | EDQM, US FDA | 2 |
| Montelukast | EDQM, US FDA | 2 |
| Glycopyrronium | US FDA | 1 |
| Glycopyrronium Bromide | EDQM | 1 |
| Indacaterol | US FDA | 1 |
| Ipratropium | EDQM | 1 |
| Levosimendan | US FDA | 1 |
| Ramipril | EDQM | 1 |
| Umeclidinium Bromide | US FDA | 1 |
| Vilanterol | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 3 | None |
| EMA | None | 1 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.4M | 21 |
| 2025 | Not reported | $10.0M | 43 |
| 2024 | Not reported | $11.0M | 42 |
| 2023 | Not reported | $9.0M | 36 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Melody Healthcare comes back tiered against every other supplier able to file there.
Start for free